Peer Review History

Original SubmissionApril 12, 2025
Decision Letter - Mohammad Faezi Ghasemi, Editor

PONE-D-25-19776Optimization of lyophilization process for long-term storage of probiotic Bacillus and Staphylococcus: Effects on survival and functionalityPLOS ONE

Dear Dr. Habib,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mohammad Faezi Ghasemi, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Additional Editor Comments :

Dear respected Authors,

Your manuscript entitled" Optimization of lyophilization process for long-term storage of probiotic Bacillus and Staphylococcus: Effects on survival and functionality was evaluated and based on our reviewers

suggestions needs revisions. So, please follows the reviewers comments and prepare point by point responses for all details. Due to use different Bacillus Spp. , staphylococcus Spp. and one strain of Lactobacillus salivarius, indicate in the title in a correct way.

Best regards,

M.Faezi (PhD)

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The data presented here are interesting. However, there are several shortcomings reduce the value of the manuscript. The language definitely requires attention, there are several typos and grammatical errors. Additionally, some parts are poorly described or confused (see also below).

Introduction:

-The manuscript requires improvement in the Introduction.

- What is the novelty of your study?

Material and Methods:

- Please add references for all protocols.

- Add name and reference of the mediums and materials.

- Antimicrobial activity section misses important data and assays may not have been conducted as recommended by antibiotic susceptibility testing guidelines. According to Clinical and Laboratory Standard Institute (CLSI) and European committee for antibiotic susceptibility testing (EUCAST) the determination of MICs with the method must use bacterial inoculum standardized at 5 x 105 CFU/ml that does not seem to be the case here. Did you control the number of CFU/ml in your inoculum? Which OD cut-off was considered positive growth? If the antimicrobial testing was not performed according to guidelines, it must be discussed in the manuscript.

- What is test bacterial strain??

Results

- The figures 1, 2, and 3 are very illegible, the quality of the charts should be improved.

- I strongly advise authors to revise the explanation of the figures. Legends of many figures has to be increased.

- What does RD mean in the tables legends?

Discussion

- Some of the content presented here are repetition of the results.

- I feel that the Discussion is too long and can be shorted by 25% or so easily without losing important information.

-Some of the content presented here are subject to the Introduction.

- I also would recommend a better organization of ideas in the Discussion.

Reviewer #2: - Strengthen the introduction by highlighting the probiotic species of Bacillus and Staphylococcus.

-Line 111, Bacterial cells washed twice with sterile distilled water. Won't washing bacteria with distilled water lead to their osmotic lysis?

-In Table one, mention the used concentration of each compound in preparation of storage conditions.

-In Table1 (Suspended cells), what are the washed cells suspended in?

-In2.4 A 1 mL sample is mixed with 9 mL of SGF. Mention the CFU of bacteria in 1 mL of sample.

-According to 2.4, the text mentions that following gastric exposure, the surviving sample is transferred into 9 mL of SIF to replicate the intestinal phase. As the population of bacteria is important in their resistance rate, in related results, mention the population of survived bacteria for second test.

- Please include reference for each section of methods.

-The effect of different excipient concentrations (2–10%) on the viability of various bacterial strains was not assessed in methods. The related results are presented in 3.1.

-In Line 202, how do you find Skim Milk Powder is the most effective excipient for probiotic strains?

-For 3.6, authors need to substantiate pathogenic bacterial growth inhibition with plate photographs.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Additional Editor Comments:

Due to use different Bacillus Spp., staphylococcus Spp. and one strain of Lactobacillus salivarius, indicate in the title in a correct way.

Response: Optimization of cryoprotectant formulations and storage temperatures for preserving viability and probiotic properties of lyophilized bacterial strains from chicken gut (L1-3)

Reviewer #1:

Introduction:

Comment: The manuscript requires improvement in the Introduction.

Response: We have thoroughly revised this section to enhance its clarity, logical flow, and relevance to the study. In particular, we have enhanced the background by including recent literature to better highlight the importance of the research topic, clearly identified the knowledge gap that our study aims to address and provided a more focused rationale for the study objectives.

Comment: What is the novelty of your study?

Response: The study employed a systematic evaluation of multiple cryoprotectant combinations across varying concentration gradients over an extended 12-month monitoring period—an approach that, to date, has not been thoroughly explored in probiotic preservation research.

Material and Methods:

Comment: Please add references for all protocols.

Response: All protocols used in this study were supported by appropriate references to ensure methodological validity and reproducibility (L125, L140, L155, L166, L188, L196, L209).

Comment: Add name and reference of the mediums and materials.

Response: The names and references of all media and materials used in this study have been clearly provided (L119, L123, L131, L134-136, L158, L168-173, L195, L197, L202, L212).

Comment: Antimicrobial activity section misses important data and assays may not have been conducted as recommended by antibiotic susceptibility test guidelines. According to the Clinical and Laboratory Standard Institute (CLSI) and European committee for antibiotic susceptibility testing (EUCAST) the determination of MICs with the method must use bacterial inoculum standardized at 5 x 105 CFU/ml that does not seem to be the case here. Did you control the number of CFU/ml in your inoculum? Which OD cut-off was considered positive growth? If the antimicrobial testing was not performed according to guidelines, it must be discussed in the manuscript.

Response: Antimicrobial activity was evaluated using a modified version of the spot-inoculation method. The concentrations of both the test pathogens and probiotic inoculum were specified in terms of CFU/mL (L213-214). In this study, we considered OD600> 0.1 as indicative of positive growth.

Comment: What is test bacterial strain??

Response: The test bacterial strains were typically pathogenic bacteria. In this study, five pathogenic strains—Escherichia coli, Yersinia enterocolitica, Vibrio cholerae, Klebsiella pneumoniae, and Salmonella typhi—were used to evaluate the antimicrobial activity of the probiotic candidates.

Results

Comment: The figures 1, 2, and 3 are very illegible, the quality of the charts should be improved.

Response: We have enhanced the resolution and clarity of these figures to ensure they are fully legible. We have also adjusted the font sizes, color contrast, and line thickness where necessary to improve visual quality and readability.

Comment: I strongly advise authors to revise the explanation of the figures. Legends of many figures has to be increased.

Response: We have carefully revised the figure legends throughout the manuscript to provide more detailed and comprehensive explanations.

Comment: What does RD mean in the table’s legends?

Response: RD means resistance degree. It refers to what extent an organism's ability to withstand or counteract a particular factor, such as a disease, a chemical, or an environmental stressor.

Discussion

Comment:

-Some of the content presented here is repetition of the results.

-I feel that the Discussion is too long and can be shorted by 25% or so easily without losing important information.

-Some of the content presented here is subject to the Introduction.

-I also would recommend a better organization of ideas in the Discussion.

Response: We have revised the Discussion section accordingly. Redundant content overlapping with the Results and Introduction has been removed, and the length has been reduced as much as possible without compromising key information. We have also reorganized the section to improve clarity and logical flow of ideas. We believe these changes have strengthened the overall quality of the manuscript.

Reviewer #2:

Comment: Strengthen the introduction by highlighting the probiotic species of Bacillus and Staphylococcus.

Response: We have revised the Introduction by emphasizing the relevance of probiotic species within the genera Bacillus and Staphylococcus. Specifically, we now highlight their roles in promoting gut health, enhancing immune response, and improving nutrient absorption (L51-63).

Comment: Line 111, Bacterial cells washed twice with sterile distilled water. Won't washing bacteria with distilled water lead to their osmotic lysis?

Response: Yes, washing bacterial cells with sterile distilled water can lead to osmotic lysis. However, in this study, the risk of lysis was minimized by limiting exposure time and handling the cells gently as per manufacturer's protocol. Moreover, all the bacterial strains examined were Gram-positive, which are inherently more resistant due to their thick peptidoglycan cell walls.

Comment: In Table one, mention the used concentration of each compound in preparation of storage conditions.

Response: The concentration of each compound is provided in the table footnote (L152-153).

Comment: In Table1 (Suspended cells), what are the washed cells suspended in?

Response: The washed cells suspended in Phosphate Buffered Saline.

Comment: In 2.4 A 1 mL sample is mixed with 9 mL of SGF. Mention the CFU of bacteria in 1 mL of sample.

Response: CFU/mL has been included (L175).

Comment: According to 2.4, the text mentions that following gastric exposure, the surviving sample is transferred into 9 mL of SIF to replicate the intestinal phase. As the population of bacteria is important in their resistance rate, in related results, mention the population of survived bacteria for second test.

Response: CFU/mL has been included (L179).

Comment: Please include reference for each section of methods.

Response: All protocols used in this study were supported by appropriate references to ensure methodological validity and reproducibility (L125, L140, L155, L166, L188, L196, L209).

Comment: The effect of different excipient concentrations (2–10%) on the viability of various bacterial strains was not assessed in methods. The related results are presented in 3.1.

Response: Thank you for pointing this out. We acknowledge the omission and have now revised the Methods section to include a detailed description of how the effects of different excipient concentrations (2–10%) on the viability of the bacterial strains were assessed (Section 2.2).

Comment: In Line 202, how do you find Skim Milk Powder the most effective excipient for probiotic strains?

Response: We have revised the Results section to clearly state that Skim Milk Powder showed a steady improvement in bacterial viability, with optimal effects observed at a concentration of 7%.

Comment: For 3.6, authors need to substantiate pathogenic bacterial growth inhibition with plate photographs.

Response: Thank you for your valuable comment. We conducted the antimicrobial test over a 12-month period, evaluating 10 variants in triplicate during each trial. Given the extensive number of plates generated, including all images in the main manuscript was impractical. Therefore, we have summarized the data using inhibition zone ranges and provided detailed results in five supplementary tables.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Mohammad Faezi Ghasemi, Editor

Optimization of cryoprotectants and storage temperatures for preserving viability and probiotic properties of lyophilized bacterial strains from chicken gut

PONE-D-25-19776R1

Dear Dr. Habib,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mohammad Faezi Ghasemi, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Mohammad Faezi Ghasemi, Editor

PONE-D-25-19776R1

PLOS ONE

Dear Dr. Habib,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mohammad Faezi Ghasemi

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .